Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer

Leonard Leibovici*, Nili Schoenfeld, Henry A. Yehoshua, Rivka Mamet, Erica Rakowsky, Asher Shindel, Abraham Atsmon

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Abstract

Porphobilinogen deaminase (PBGD), one of the enzymes in the pathway of heme synthesis, was found to be elevated in peripheral mononuclear cells of 60% of patients with epithelial tumors and metastatic spread, but only in 14% of patients with tumor and no evidence of metastases. The combination of both high lactic dehydrogenase and high PBGD afforded a sensitivity of 40%, but a specificity of 96% in diagnosing metastatic spread.

Original languageEnglish
Pages (from-to)2297-2300
Number of pages4
JournalCancer
Volume62
Issue number11
DOIs
StatePublished - 1 Dec 1988

Fingerprint

Dive into the research topics of 'Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer'. Together they form a unique fingerprint.

Cite this